What does Jones Hill Capital LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Jones Hill Capital LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

BIOMARIN PHARMACEUTICAL INC

$72M1.3M15.4%

VERTEX PHARMACEUTICALS INC

$48M109K10.4%

VAXCYTE INC

$37M645K8.0%

NUVALENT INC

$31M301K6.6%

CAPRICOR THERAPEUTICS INC

$28M909K5.9%

TERNS PHARMACEUTICALS INC

$27M521K5.9%

BICARA THERAPEUTICS INC

$25M1.3M5.4%

ANI PHARMACEUTICALS INC

$24M319K5.3%

ULTRAGENYX PHARMACEUTICAL IN

$24M1.2M5.2%

ENLIVEN THERAPEUTICS INC

$23M593K5.0%

Filing history loading…